Alteration of cellular and acellular alveolar and bronchiolar walls produced by hypocholesteremic drug AY9944.
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001593:Benzyl Compounds / Q000494:pharmacology; D001980:Bronchi / Q000187:drug effects* / Q000378:metabolism; D002473:Cell Wall / Q000187:drug effects; D002776:Cholestanes / Q000378:metabolism; D002923:Cilia; D003510:Cyclohexanes / Q000494:pharmacology*; D004721:Endoplasmic Reticulum; D002479:Inclusion Bodies; D008264:Macrophages / Q000378:metabolism; D008744:Methylamines / Q000494:pharmacology; D008854:Microscopy, Electron; D011650:Pulmonary Alveoli / Q000187:drug effects* / Q000378:metabolism; D011663:Pulmonary Surfactants / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012270:Ribosomes; D013261:Sterols / Q000378:metabolism
D000924:Anticholesteremic Agents; D001593:Benzyl Compounds; D002776:Cholestanes; D003510:Cyclohexanes; D008744:Methylamines; D011663:Pulmonary Surfactants; D013261:Sterols